<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>nanoparticle on XiaO | 缄默之语</title>
    <link>https://urz.one/tags/nanoparticle/</link>
    <description>Recent content in nanoparticle on XiaO | 缄默之语</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>cmn-Hans-CN</language>
    <lastBuildDate>Tue, 27 Apr 2021 00:00:00 +0000</lastBuildDate><atom:link href="https://urz.one/tags/nanoparticle/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>纳米药物指导原则</title>
      <link>https://urz.one/cn/2021-04-27/three-guiding-principles-of-nanomedicine-from-cde/</link>
      <pubDate>Tue, 27 Apr 2021 00:00:00 +0000</pubDate>
      
      <guid>https://urz.one/cn/2021-04-27/three-guiding-principles-of-nanomedicine-from-cde/</guid>
      <description>近年来随着纳米技术的发展，纳米药物研究逐渐成为药物开发热点之一。目前国际药监机构对纳米类药物尚无统一认识，未形成统一监管要求，但总体持谨慎态</description>
    </item>
    
    <item>
      <title>伊素复合纳米颗粒</title>
      <link>https://urz.one/cn/2020-06-26/camptothecin-curcumin-nanoparticle/</link>
      <pubDate>Fri, 26 Jun 2020 00:00:00 +0000</pubDate>
      
      <guid>https://urz.one/cn/2020-06-26/camptothecin-curcumin-nanoparticle/</guid>
      <description>伊素复合纳米颗粒是一个基于伊立替康与姜黄素联合用药的抗肿瘤纳米制剂，其彻底消除了伊立替康引起的致死性腹泻等副作用，同时显著增强了其抗肿瘤治疗</description>
    </item>
    
  </channel>
</rss>
